Comparison of the diagnostic criteria for gestational diabetes mellitus in China

( views:211, downloads:0 )
Author:
WEI Yu-mei(Department of Obstetrics and Gynecology,Peking University First Hospital, Bering 100034, China)
YANG Hui-xia(Department of Obstetrics and Gynecology,Peking University First Hospital, Bering 100034, China)
Journal Title:
CHINESE JOURNAL OF OBSTETRICS AND GYNECOLOGY
Issue:
Volume 46, Issue 08, 2011
DOI:
10.3760/cma.j.issn.0529-567x.2011.08.005
Key Word:
Diabetes,gestational;Diagnosis;Reference standards

Abstract: Objective To investigate the relationship between gestational hyperglycemia and adverse pregnancy outcomes and find out the optimum diagnostic criteria of gestational diabetes mellitus in China. Methods A retrospective population-based study of 14 593 pregnant women, who delivered between Jan. 2005 and Dec. 2009 and accepted the gestational diabetes mellitus ( GDM ) screening and diagnosis was performed. The prevalence of gestational hyperglycemia according to different criteria was calculated, and the incidence of adverse pregnant outcomes relation to gestational hyperglycemia according to different criteria was analyzed. Results ( 1 ) According to National Diabetes Data Group (NDDG) criteria and International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, the prevalence of gestational hyperglycemia that intervention required was 8.9% (1293/14 593 ) and 14.7% (2138/14 593 )respectively; the prevalence of gestational hyperglycemia differed significantly between NDDG and IADPSG criteria ( P < 0. 05 ). ( 2 ) The prevalence of macrosomia, large for gestational ages ( LGA), cesarean section,preterm birth and neonatal hypoglycemia etc would increase in gestational glucose metabolic disorders according to any criteria. The prevalence of the complications in gestational hyperglycemia according to NDDG criteria, IADPSG criteria and the patients with normal glucose metabolism is as follows, macrosomia:8.4% ( 108/1293), 11.3% (241/2138) and 6. 7% ( 835/12 403 ); LGA: 9. 7% ( 125/1293 ), 11.7% (250/2138) and 5.5% (687/12 403); cesarean section: 59. 0% (763/1293), 60. 4% ( 1291/2138 ) and 51.6%(6397/12403); preterm birth: 11.4% (147/1293), 9.5% (203/2138) and 6.3% (777/12 403); neonatal hypoglycemia: 2. 6% ( 33/1293 ), 2. 2% (46/2138) and 0. 7% ( 89/12 403 ). ( 3 )About 71.3% (922/1293) of the gestational hyperglycemia according to NDDG criteria could be well control only by diet control. Conclusion The prevalence of perinatal complications would increase in gestational hyperglycemia that achieved IADPSG criteria without intervention, so IADPSG criteria is reasonable in China.

  • [1]O'Sullivan JB,Mahan CM.Criteria for the oral glucose tolerance test in pregnancy.Diabetes,1964,13:278-285.
  • [2]National Diabetes Data Group.Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.Diabetes,1979,28:1039-1057.
  • [3]Carpenter MW,Coustan DR.Criteria for screening tests for gestational diabetes.Am J Obstet Gynecol,1982,144:768-773.
  • [4]Metzger BE,Coustan DR.Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitns.The Organizing Committee.Diabetes Care,1998,21:161-167.
  • [5]American Diabetes Association.Gestational diabetes mellitus.Diabetes Care,2000,23:77-79.
  • [6]American Diabetes Association.Gestational diabetes mellitus.Diabetes Care,2002,25:94-96.
  • [7]American Diabetes Association.Gestational diabetes mellitus.Diabetes Care,2003,26:103-105.
  • [8]American Diabetes Association.Gestational diabetes mellitts.Diabetes Care,2004,27:88-90.
  • [9]中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案).中华妇产科杂志,2007,42:426-428.
  • [10]Langer O,Yogev Y,Most O,et al.Gestational diabetes:the consequences of not treating.Am J Obstet Gynecol,2005,192:989 -997.
  • [11]Fan ZT,Gao XL,Yang HX.Popularizing labor analgesia in China.Int J Gynecol Obstet,2007,98:205-207.
  • [12]Crowther CA,Hiller JE,Moss JR,et al.Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.N Engl J Med,2005,352:2477-2486.
  • [13]Landon MB,Spong CY,Thom E,et al.A mulficenter,randomized trial of treatment for mild gestational diabetes.N Engl J Med,2009,361:1339-1348.
  • [14]American Diabetes Association.Standards of medical care in diabetes-2010.Diabetes Care,2010,33:11-61.
  • [15]Hadar E,Oats J,Hod M.Towards new diagnostic criteria for diagnosing GDM:the HAPO study.J Perinat Med,2009,37:447-449.
  • [16]American Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes Care,2011,34:62-69.
  • [17]International Association of Diabetes and Pregnancy Study Groups Consensus Panel,Metzger BE,Gabbe SG,et al.International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.Diabetes Care,2010,33:676-682.
  • [18]HAPO Study Cooperative Research Group,Metzger BE,Lowe LP,et al.Hyperglycemia and adverse pregnancy outcomes.N Engl J Med,2008,358:1991-2002.
  • [19]HAPO Study Cooperative Research Group.The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study.Int J Gyaecol Obstet,2002,78:69-77.
  • [20]Soonthompun S,Soonthornpun K,Aksonteing J,et al.A comparison between a 75-g and 100-g oral glucose tolerance test in pregnant women.lnt J Gynecol Obstet,2003,81:169-173.
  • [21]Mello G,Elena P,Ognibene A,et al.Lack of concordance between the 75-g and 100-g glucose load tests for the diagnosis of gestational diabetes mellitus.Clin Chem,2006,52:1679-1684.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn